Abstract-The role of the neuronal NO synthase (nNOS or NOS1) enzyme in the control of cardiac function still remains unclear. Results from nNOS Ϫ/Ϫ mice or from pharmacological inhibition of nNOS are contradictory and do not pay tribute to the fact that probably spatial confinement of the nNOS enzyme is of major importance. We hypothesize that the close proximity of nNOS and certain effector molecules like L-type Ca 2ϩ -channels has an impact on myocardial contractility. To test this, we generated a new transgenic mouse model allowing conditional, myocardial specific nNOS overexpression. Western blot analysis of transgenic nNOS overexpression showed a 6-fold increase in nNOS protein expression compared with noninduced littermates (nϭ12; PϽ0.01). Measuring of total NOS activity by conversion of [3 H]-L-arginine to [ 3 H]-L-citrulline showed a 30% increase in nNOS overexpressing mice (nϭ18; PϽ0.05). After a 2 week induction, nNOS overexpression mice showed reduced myocardial contractility. In vivo examinations of the nNOS overexpressing mice revealed a 17Ϯ3% decrease of ϩdp/dt max compared with noninduced mice (PϽ0.05). Likewise, ejection fraction was reduced significantly (42% versus 65%; nϭ15; PϽ0.05). Interestingly, coimmunoprecipitation experiments indicated interaction of nNOS with SR Ca 2ϩ ATPase and additionally with L-type Ca 2ϩ -channels in nNOS overexpressing animals. Accordingly, in adult isolated cardiac myocytes, I Ca,L density was significantly decreased in the nNOS overexpressing cells. Intracellular Ca 2ϩ -transients and fractional shortening in cardiomyocytes were also clearly impaired in nNOS overexpressing mice versus noninduced littermates. In conclusion, conditional myocardial specific overexpression of nNOS in a transgenic animal model reduced myocardial contractility. We suggest that nNOS might suppress the function of L-type Ca 2ϩ -channels and in turn reduces Ca 2ϩ -transients which accounts for the negative inotropic effect. (Circ Res. 2007;100:e32-e44.) Key Words: nNOS Ⅲ contractility Ⅲ excitation Ⅲ contraction coupling Ⅲ conditional overexpression S everal studies have demonstrated neuronal NO synthase (nNOS) protein expression within cardiac myocytes. 1 Specifically, nNOS has been localized to the sarcolemma 2,3 and the sarcoplasmatic reticulum (SR), 4 where it has been shown to be in close proximity to the SR Ca 2ϩ -release channel (RyR2) 5 and the SR Ca 2ϩ ATPase. However, the impact of nNOS on myocardial contractility remains largely controversial. Results from nNOS Ϫ/Ϫ mice and from pharmacological inhibition of nNOS provided insights into the role of nNOS in the cardiovascular system. But these approaches suffer from complete nNOS blockade and did not take into account a possible translocation of nNOS to specific subcellular sites. Some authors have shown, that inhibition of nNOS activity, via gene disruption or by pharmacological inhibition, enhanced basal contractility. 7,8 In the latter study, the positive inotropic effects of nNOS inhibition or gene disruption were related to ...